FiveT Investment Management Ltd 13D and 13G filings for Inhibikase Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-24 12:27 pm Sale | 2023-02-22 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 223,500 4.780% | -29,333 (-11.60%) | Filing |
| 2023-01-31 11:59 am Unchanged | 2023-01-25 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 252,833 4.120% | 0 (Unchanged) | Filing |
| 2022-01-11 12:04 pm Purchase | 2022-01-10 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 252,833 6.030% | 44,500 (+21.36%) | Filing |
| 2021-12-15 12:52 pm Sale | 2021-12-14 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 208,333 4.970% | -35,786 (-14.66%) | Filing |
| 2021-06-21 12:01 pm Purchase | 2021-06-16 | 13D | Inhibikase Therapeutics, Inc. IKT | FiveT Investment Management Ltd | 244,119 5.830% | 244,119 (New Position) | Filing |